Eric Libre, Eric Libre, MD, FACP, FCCP

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Consulting Fee
    Ineligible company: 
    GlaxoSmithKline
    Topic: 
    COPD, Asthma and RSV
    Date added: 
    11/28/2023
    Mitigation strategy: 
    Attest
    Relationship end date: 
    11/28/2023
    Date reviewed: 
    12/07/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Consulting Fee
    Ineligible company: 
    AstraZeneca
    Topic: 
    Asthma
    Date added: 
    11/28/2023
    Mitigation strategy: 
    Attest
    Relationship end date: 
    11/28/2023
    Date reviewed: 
    12/07/2023
Return to 2023 Inova Fairfax Medicine Grand Rounds (Enduring Material) 12.05.2023